You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 97 No. 3, March 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Changing concepts of failures after retinal detachment surgery

W. F. Rachal and T. C. Burton

One thousand eighty-eight consecutive operations for retinal detachment were analyzed to determine the influence of current methods of examination and treatment on failures following surgery. The majority of failures were produced by preretinal membranes formation (33%) and massive preretinal retraction (27%). Other causes of failure included undetected retinal breaks (13%), inadequate scleral buckel (10%), new retinal breaks (8%), inadequate chorioretinal reaction (7%), and iatrogenic retinal breaks (2%). Primary operations yielded an initial cure rate of 76%. Successful reoperations raised the final cure rate to 89%. Reoperations were associated more frequently with preretinal membrane formation and chance of recognition and management of preretinal membrane formation. Except for new retinal tears and massive preretinal retraction, surgical failures can be avoided by improved utilization of current examination and operative techniques.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tailored vitrectomy and laser photocoagulation without scleral buckling for all primary rhegmatogenous retinal detachments
Johansson et al.
Br. J. Ophthalmol. 2006;90:1286-1291.
ABSTRACT | FULL TEXT  

An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy
Cardillo et al.
Br. J. Ophthalmol. 2004;88:1201-1205.
ABSTRACT | FULL TEXT  

p38 MAPK Mediates the Expression of Type I Collagen Induced by TGF-{beta}2 in Human Retinal Pigment Epithelial Cells ARPE-19
Kimoto et al.
IOVS 2004;45:2431-2437.
ABSTRACT | FULL TEXT  

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study
Kon et al.
Br. J. Ophthalmol. 2000;84:506-511.
ABSTRACT | FULL TEXT  

Molecular therapy in ocular wound healing
CORDEIRO et al.
Br. J. Ophthalmol. 1999;83:1219-1224.
FULL TEXT  

An Intravitreal Sustained-Release Triamcinolone and 5-Fluorouracil Codrug in the Treatment of Experimental Proliferative Vitreoretinopathy
Yang et al.
Arch Ophthalmol 1998;116:69-77.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.